Comparison of Electrospun and Extruded Soluplus®-Based Solid Dosage Forms of Improved Dissolution

Keserű, 2009, The influence of lead discovery strategies on the properties of drug candidates, Nat Rev Drug Discov, 8, 203, 10.1038/nrd2796

Lipinski, 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv Drug Deliv Rev, 23, 3, 10.1016/S0169-409X(96)00423-1

Lipinski, 2000, Drug-like properties and the causes of poor solubility and poor permeability, J Pharm Toxicol Methods, 44, 235, 10.1016/S1056-8719(00)00107-6

Prentis, 1988, Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964—1985), Br J Clin Pharmacol, 25, 387, 10.1111/j.1365-2125.1988.tb03318.x

Amidon, 1995, A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res, 12, 413, 10.1023/A:1016212804288

Pouton, 2006, Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system, Eur J Pharm Sci, 29, 278, 10.1016/j.ejps.2006.04.016

Sugano, 2007, Solubility and dissolution profile assessment in drug discovery, Drug Metab Pharmacokinet, 22, 225, 10.2133/dmpk.22.225

Verreck, 2003, Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion—Part I, Int J Pharm, 251, 165, 10.1016/S0378-5173(02)00591-4

Yano, 2010, Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: Comparison between melt extrusion and wet extrusion, AAPS Pharm Sci Tech, 11, 885, 10.1208/s12249-010-9448-2

Sauceau, 2011, New challenges in polymer foaming: A review of extrusion processes assisted by supercritical carbon dioxide, Progr Polym Sci, 36, 749, 10.1016/j.progpolymsci.2010.12.004

Verreck, 2005, The effect of pressurized carbon dioxide as a temporary plasticizer and foaming agent on the hot stage extrusion process and extrudate properties of solid dispersions of itraconazole with PVP-VA 64, Eur J Pharm Sci, 26, 349, 10.1016/j.ejps.2005.07.006

Nagy ZK, Sauceau M, Nyúl, Rodier E, Vajna B, Marosi G, Fages J. Use of supercritical CO2-aided and conventional melt extrusion for enhancing the dissolution rate of an active pharmaceutical ingredient. Polym Adv Technol. In Press.

Windbergs, 2009, Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates, Int J Pharm, 381, 184, 10.1016/j.ijpharm.2009.03.002

Windbergs, 2010, Two-step solid lipid extrusion as a process to modify dissolution behavior, AAPS Pharm Sci Tech, 11, 2, 10.1208/s12249-010-9395-y

Breitenbach, 2002, Melt extrusion: From process to drug delivery technology, Eur J Pharm Biopharm, 54, 107, 10.1016/S0939-6411(02)00061-9

Lakshman, 2008, Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug, Mol Pharm, 5, 994, 10.1021/mp8001073

Noyes, 1897, The rate of solution of solid substances in their own solutions, J Am Chem Soc, 19, 930, 10.1021/ja02086a003

Hancock, 1997, Characteristics and significance of the amorphous state in pharmaceutical systems, J Pharm Sci, 86, 1, 10.1021/js9601896

Patterson, 2005, The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds, J Pharm Sci, 94, 1998, 10.1002/jps.20424

Guns, 2011, Comparison between hot-melt extrusion and spray-drying for manufacturing solid dispersions of the graft copolymer of ethylene glycol and vinylalcohol, Pharm Res, 28, 673, 10.1007/s11095-010-0324-2

Ostwald, 1900, Über die vermeintliche Isomerie des roten und gelben Quecksilberoxyds und die Oberflächenspannung fester Körper, Zeitschrift für Physikalische Chemie, 34, 495, 10.1515/zpch-1900-3431

Freundlich, 1909

Van Eerdenbrugh, 2010, Solubility increases associated with crystalline drug nanoparticles: Methodologies and significance, Mol Pharm, 7, 1858, 10.1021/mp100209b

Patterson, 2007, Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling, Int J Pharm, 336, 22, 10.1016/j.ijpharm.2006.11.030

Marsac, 2010, Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly (vinyl pyrrolidone), J Pharm Sci, 99, 169, 10.1002/jps.21809

Weuts, 2010, Physicochemical properties of the amorphous drug, cast films, and spray dried powders to predict formulation probability of success for solid dispersions: Etravirine, J Pharm Sci, 100, 260, 10.1002/jps.22242

Brouwers, 2009, Supersaturating drug delivery systems: The answer to solubility-limited oral bioavailability, J Pharm Sci, 98, 2549, 10.1002/jps.21650

Alonzo, 2010, Understanding the behavior of amorphous pharmaceutical systems during dissolution, Pharm Res, 27, 608, 10.1007/s11095-009-0021-1

Molnár, 2011, Determination of tensile strength of electrospun single nanofibers through modeling tensile behavior of the nanofibrous mat, Comp. Part B: Engin

Kostakova, 2009, Composite nanofibers produced by modified needleless electrospinning, Materials Lett, 63, 2419, 10.1016/j.matlet.2009.08.014

Huang, 2010, Dynamic wettability and contact angles of poly (vinylidene fluoride) nanofiber membranes grafted with acrylic acid, Express Polym Lett, 4, 551, 10.3144/expresspolymlett.2010.69

Thakur, 2008, Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing, Int J Pharm, 364, 87, 10.1016/j.ijpharm.2008.07.033

Rho, 2006, Electrospinning of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing, Biomaterials, 27, 1452, 10.1016/j.biomaterials.2005.08.004

Kolacna, 2007, Biochemical and biophysical aspects of collagen nanostructure in the extracellular matrix, Physiol Res, 56, 51, 10.33549/physiolres.931302

Schnell, 2007, Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-ε-caprolactone and a collagen/poly-ε-caprolactone blend, Biomaterials, 28, 3012, 10.1016/j.biomaterials.2007.03.009

Verreck, 2003, Preparation and characterization of nanofibers containing amorphous drug dispersions generated by electrostatic spinning, Pharm Res, 20, 810, 10.1023/A:1023450006281

Yu, 2009, Ultrafine ibuprofen loaded polyvinylpyrrolidone fiber mats using electrospinning, Polymer Int, 58, 1010, 10.1002/pi.2629

Yu, 2009, Oral fast-dissolving drug delivery membranes prepared from electrospun polyvinylpyrrolidone ultrafine fibers, Nanotechnology, 20, 055104, 10.1088/0957-4484/20/5/055104

Nagy, 2010, Electrospun water soluble polymer mat for ultrafast release of Donepezil HCl, Express Polym Lett, 4, 763, 10.3144/expresspolymlett.2010.92

Fathi-Azarbayjaniand, 2010, Single and multi-layered nanofibers for rapid and controlled drug delivery, Chem Pharm Bull, 58, 143, 10.1248/cpb.58.143

Yu, 2010, Dissolution improvement of electrospun nanofiber-based solid dispersions for acetaminophen, AAPS PharmSciTech, 11, 809, 10.1208/s12249-010-9438-4

Vasconcelos, 2007, Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs, Drug Discov Today, 12, 1068, 10.1016/j.drudis.2007.09.005

Hardung, 2010, Combining HME & solubilization: Soluplus®—The solid solution, Drug Deliv Technol, 10, 20

Doggrell, 2001, The spironolactone renaissance, Expert Opin Invest Drugs, 10, 943, 10.1517/13543784.10.5.943

Patyi, 2010, Thermal and spectroscopic analysis of inclusion complex of spironolactone prepared by evaporation and hot melt methods, J Thermal Anal Calorimetry, 102, 349, 10.1007/s10973-010-0936-0

Shenoy, 2005, Role of chain entanglements on fiber formation during electrospinning of polymer solutions: Good solvent, non-specific polymer–polymer interaction limit, Polymer, 46, 3372, 10.1016/j.polymer.2005.03.011

Liu, 2011, A new spurts controllable electrospinning collecting device designed basing on advanced motion control, Applied Mechanics Mater, 44, 1698, 10.4028/www.scientific.net/AMM.90-93.1698

Vajna, 2010, Raman microscopic evaluation of technology dependent structural differences in tablets containing imipramine model drug, J Pharm Biomed Anal, 51, 30, 10.1016/j.jpba.2009.07.030

Rajabi, 2008, Study of interaction of spironolactone with hydroxypropyl-[beta]-cyclodextrin in aqueous solution and in solid state, J Mol Structure, 878, 78, 10.1016/j.molstruc.2007.07.043